Amanote Research
Register
Sign In
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo--Lactamase Inhibitors
doi 10.1021/acs.jmedchem.7b01728.s002
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
In Silico Approaches for Fragment-Based Drug Design
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
Electrophilic Fragment-Based Design of Reversible Covalent Kinase Inhibitors
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry
Discovery of Novel KRAS-PDE Inhibitors by Fragment-Based Drug Design
Correction to Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-Β-Lactamase-1
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
New Delhi Metallo-Β-Lactamase (NDM)
Biochemist
Biochemistry
Genetics
Molecular Biology
Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo--Lactamase Inhibitors
Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo--Lactamase Inhibitors
Fragment-Based Design of Small Molecule X-Linked Inhibitor of Apoptosis Protein Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
New Delhi Metallo- -Lactamase-1 in Enterobacteriaceae: Emerging Resistance
CMAJ
Medicine
